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doi:10.1016/j.ejvs.2009.05.013Abstract Objectives: To summarise the present evidence for an association between circu-
lating fibrinogen or D-dimer and presence of abdominal aortic aneurysm (AAA) presence.
Design: MEDLINE database was searched to identify all case-control studies that compared
plasma fibrinogen or D-dimer concentrations between patients with AAA and subjects without
AAA. For each study, data regarding fibrinogen or D-dimer concentrations in both the AAA and
control groups were used to generate mean differences (MDs) and 95% confidence intervals
(CIs). Study-specific estimates were combined using inverse variance-weighted average of
logarithmic MDs in both fixed- and random-effects models.
Results: Our search identified 10 eligible studies including 834 cases with AAA and 6971
controls without AAA for fibrinogen and six studies including 264 patients with AAA and 403
subjects without AAA for D-dimer. Pooled analysis demonstrated significantly higher fibrinogen
(fixed-effects MD, 0.37 g l1; 95% CI: 0.30e0.44 g l1) and D-dimer (random-effects MD:
415.36 ng ml1; 95% CI: 128.97e701.76 ng ml1) concentrations in the AAA group than those
in the control group.
Conclusions: We found that plasma fibrinogen and D-dimer concentrations are likely to be
higher in cases with AAA than control subjects. Higher plasma fibrinogen and D-dimer concen-
trations may be associated with the presence of AAA.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Circulating concentrations of many kinds of biomarkers
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ty for Vascular Surgery. Publisheabdominal aortic aneurysm (AAA) and subjects without AAA
to assess their possible role in the pathogenesis or
progression of AAA. Circulating biomarkers could play a role
in the diagnosis of AAA and may have a role in predicting
subsequent progression of AAA.1 These biomarkers included
extracellular matrix markers, matrix-degrading enzymes,
proteins associated with thrombosis, lipids and markers of
inflammation. Proteins involved in, stimulated by ord by Elsevier Ltd. All rights reserved.
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dimer, have been the biomarkers most commonly assessed
in AAA.1 To summarise the present evidence for an associ-
ation between circulating fibrinogen or D-dimer and AAA
presence, we performed a systematic review and meta-
analysis of case-control studies that compared plasma
fibrinogen or D-dimer concentrations between patients
with AAA and subjects without AAA.Materials and Methods
Search strategy
All case-control studies that compared plasma fibrinogen or
D-dimer concentrations between patients with AAA and
subjects without AAA were identified using a two-level
search strategy. First, a public domain database (MEDLINE)
was searched using a web-based search engine (PubMed).
Second, relevant studies were identified through a manual
search of secondary sources including references of initially
identified articles and a search of reviews and commen-
taries. All references were downloaded for consolidation,
elimination of duplicates and further analysis. The MEDLINE
database was searched from January 1966 to November
2008. MeSH keywords included fibrinogen; fibrin fragment
D; and aortic aneurysm, abdomen. Text keywords included
fibrinogen, fibrin fragment D, D-dimer and abdominal
aortic aneurysm.Study selection and data abstraction
Studies considered for inclusion met the following criteria:
the design was a case-control study; the study population
was patients with AAA and subjects without AAA; and main
outcomes included means and standard deviations (SDs) of
plasma fibrinogen or D-dimer concentrations in the AAA and
control groups. Data regarding detailed inclusion criteria
and plasma fibrinogen or D-dimer concentrations were
abstracted (as available) from each individual study.Statistical analysis
We conducted a meta-analysis of summary statistics from
the individual studies because detailed, patient-level data
were not available for all studies. For each study, data
regarding plasma fibrinogen or D-dimer concentrations in
both the AAA and control groups were used to generate
mean differences (MDs) and 95% confidence intervals (CIs).
In articles reporting the median and the interquartile range
(IQR), we took the median to be representative of the mean
and converted the IQR into an SD by divided it by 1.35.2
When the concentrations were stated separately in
subgroups of the AAA or control group, we combined them
as values of the AAA or control group by the use of standard
formulae.2 Study-specific estimates were combined using
inverse variance-weighted average of logarithmic MDs in
both fixed- and random-effects models. Between-study
heterogeneity was analysed by means of standard c2 tests.
Where no significant statistical heterogeneity wasidentified, the fixed-effect estimate was used preferen-
tially as the summary measure. Sensitivity analyses were
performed to assess the contribution of each study to the
pooled estimate by excluding individual studies one at
a time and recalculating the pooled MD estimates for the
remaining studies. To assess the impact of differential
control selection on the pooled estimate, the association of
plasma fibrinogen or D-dimer and AAA presence was
explored separately in studies with healthy controls.
Publication bias was assessed graphically using a funnel plot
and mathematically using an adjusted rank-correlation
test, according to the method of Begg and Mazumdar.3 All
analyses were conducted using Review Manager (RevMan)4
and Microsoft Excel (Version 11.5.0).
Results
Our search identified 12 case-control studies5e16 that
compared plasma fibrinogen concentrations and seven
studies7,12,13,15,17e19 that compared plasma D-dimer
concentrations between patients with AAA and subjects
without AAA. Of these studies, we excluded two studies15,16
in which the mean and SD of fibrinogen or D-dimer
concentrations could not be abstracted. In total, our meta-
analysis included 10 studies5e14 and data on 834 cases with
AAA and 6 971 controls without AAA for fibrinogen, and six
studies7,12,13,15,17e19 and data on 264 patients with AAA and
403 subjects without AAA for D-dimer.
Plasma fibrinogen concentrations and AAA
presence
Eight5,7,8,10e14 of the 10 studies reported plasma fibrinogen
concentrations in men and women combined, whereas the
study by Al-Barjas et al.6 stated those in men exclusively
and the study by Singh et al.9 reported those separately in
men and women. Four5,9,11,12 of the 10 studies stated the
means and SDs of fibrinogen concentrations, whereas the
other six studies6e8,10,13,14 stated the medians and IQRs. In
the latter six studies, we obtained the means and SDs by
means of the standard formulae.2 Eight5e7,9,10,12e14 of the
10 studies reported plasma fibrinogen concentrations in
healthy controls, whereas the other two studies stated
those separately in healthy controls and controls with
atherosclerosis (peripheral arterial disease8 or ilio-femoral
stenosis11). In the latter two studies, we combined the
separately reported concentrations as values in the control
group by the use of the standard formulae.2
Six6e10,13 of the 10 individual studies demonstrated
significantly higher plasma fibrinogen concentrations, and
three studies5,12,14 showed non-significantly higher ones in
the AAA group than those in the control group. Pooled
analysis of the 10 studies (representing 834 cases with AAA
and 6971 controls without AAA) demonstrated significantly
higher fibrinogen concentrations in the AAA group than
those in the control group in fixed-effect models (MD,
0.37 g l1; 95% CI: 0.30e0.44 g l1; p< 0.00001 (Fig. 1)).
There was no significant study heterogeneity of results
(pZ 0.44) and accordingly no difference in the pooled
result from random-effects modelling. To assess the impact
of qualitative heterogeneity in study design and control
Figure 1 Plasma fibrinogen concentrations among cases with abdominal aortic aneurysm (AAA) and controls without AAA.
SDZ standard deviation; CIZ confidence interval.
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several sensitivity analyses. In general, exclusion of any
single study from the analysis did not substantively alter
the overall result of our analysis. Additionally, combining
MDs between plasma fibrinogen concentrations in the AAA
group and those in the healthy control group (representing
834 patients with AAA and 6898 healthy controls) did not
substantially change the pooled point estimate (random-
effects MD, 0.42 g dl1; 95% CI: 0.34e0.53 g dl1;
p< 0.00001) (heterogeneity, pZ 0.04).Plasma D-dimer concentrations and AAA presence
All of the six studies reported plasma D-dimer concentra-
tions in men and women combined. Three12,18,19 of the six
studies stated the means and SDs of D-dimer concentra-
tions, whereas the other three studies7,13,17 reported the
medians and IQRs. In the latter three studies, the means
and SDs were obtained by means of the standard formulae.2
Five7,12,13,17,18 of the six studies stated plasma D-dimer
concentrations in healthy controls, whereas only the study
by Aramoto et al.19 reported those in controls with
arteriosclerosis obliterans.
Five7,12,13,17,19 of the six individual studies demonstrated
significantly higher plasma D-dimer concentrations,
whereas only the study by Serino et al.18 showed non-
significantly higher ones in the AAA group than those in the
control group. Pooled analysis of the six studies (repre-
senting 264 cases with AAA and 403 control subjects)
demonstrated significantly higher D-dimer concentrations
in the AAA group than those in the control group in random-
effect models (MD, 415.36 ngml1; 95% CI: 128.97eFigure 2 Plasma D-dimer concentrations among cases with a
SDZ standard deviation; CIZ confidence interval.701.76 ngml1; pZ 0.004 (Fig. 2)). There was significant
study heterogeneity of results (p< 0.00001). In general,
exclusion of any single study from the analysis did not
substantively alter the overall result of our analysis.
Combining five studies with healthy control group7,12,13,17,18
(representing 223 patients with AAA and 373 healthy
controls) did not substantially change the pooled point
estimate (random-effects MD, 364.00 ngml1; 95% CI:
93.32e634.68 ngml1; pZ 0.008) (heterogeneity,
p< 0.00001).
Publication bias
To assess publication bias we generated a funnel plot of the
logarithm of effect size versus the standard error for each
study. There was no evidence of significant publication bias
(pZ 0.6767 for fibrinogen; pZ 0.8510 for D-dimer; by Begg
adjusted rank-correlation test).
Discussion
The results of our analysis suggest that plasma fibrinogen
and D-dimer concentrations may be higher in patients with
AAA than those in subjects without AAA. Our analysis,
however, must be viewed in the context of its limitations.
First, there was qualitative heterogeneity in participant
selection among included studies. Although eight of the 10
studies for fibrinogen reported the concentrations in
combined men and women, one study stated those in
men exclusively and another study reported those
separately in men and women. Second, heterogeneity in
control selection was present. Eight of the 10 studies forbdominal aortic aneurysm (AAA) and controls without AAA.
276 H. Takagi et al.fibrinogen stated the concentrations in healthy control,
whereas the other two studies reported those separately in
healthy controls and controls with atherosclerosis. In the
sensitivity analysis, we combined MDs between the
concentrations in the AAA group and those in the healthy
control group, and the pooled point estimate was not
substantively changed. Although five of the six studies for
D-dimer stated the concentration in healthy controls, the
other study reported those in controls with arteriosclerosis.
Combining the five studies with healthy controls did not
substantially change the pooled estimate. Despite these
acknowledged limitations, we found that, based on
a systematic review and meta-analysis, plasma fibrinogen
and D-dimer concentrations are likely to be higher in cases
with AAA than control subjects. Higher plasma fibrinogen
and D-dimer concentrations may be associated with AAA
presence. High fibrinogen levels in patients with AAA may
reflect an underlying inflammatory process.6 Aortic aneu-
rysms appear to be an important source of circulating
interleukin-6, which has a pivotal role in stimulating the
acute-phase response and elevates the circulating
concentrations of several plasma proteins, including
fibrinogen and C-reactive protein.20 An AAA may not
develop because of elevated levels of fibrinogen but may
cause elevated levels of fibrinogen. It has been shown in
previous articles that the measured plasma levels of
fibrinogen seem to correlate much more to the amount of
parietal thrombus than to the size of the aneurysm.
Al-Barjas et al.6 demonstrated that fibrinogen was posi-
tively correlated with the percentage of intraluminal
thrombi occupying the lumen (rZ 0.358; p< 0.05), and the
correlation could be explained by the effect of fibrinogen
on clot structure. Raised fibrinogen levels increase fibri-
nopeptide cleavage, causing activation and the formation
of a tight rigid fibril gel with thicker fibres and reduced
permeation.21,22
Two case-control studies,15,16 in which we could not
abstract the mean and SD of fibrinogen or D-dimer
concentrations, were excluded from the present meta-
analysis. These studies including very small number of
participants showed no association between plasma fibrin-
ogen or D-dimer concentrations and AAA presence. In the
study by Milne et al. including 23 patients with AAA and 16
control patients with symptomatic carotid artery
stenoses,15 all patients had plasma fibrinogen levels within
normal range although these tended to be at the upper end
of the range, whereas one patient had a minimally elevated
level of D-dimer. Fligelstone et al.16 compared 20 patients
with claudication, 20 patients with critical limb ischaemia
and 20 patients prior to elective AAA surgery to 20 general
surgical controls. The fibrinogen level was normal for all
patients in the claudication and AAA groups but was
significantly elevated in seven patients in the critical
ischaemia group.
Plasma fibrinogen is increased by smoking; thus, the
association of fibrinogen with AAA could simply reflect the
well-established link between smoking and AAA.1 Singh
et al.9 in the multivariate model including smoking
demonstrated that a high plasma fibrinogen level increased
the risk of AAA significantly and independently in men
(adjusted odds ratio [OR], 1.42, 95% CI: 1.22e1.67; p< 0.001)
but not women (adjusted OR, 1.23; 95% CI: 0.91e1.66;pZ 0.18). After adjustment for age, sex, pack years,
a history of cardiovascular disease and the ankle brachial
pressure index, Lee et al.13 showed that a SD increase
(þ0.76 g l1) in fibrinogen was associated with a significant
increase in risk of AAA (OR, 1.51; 95% CI: 1.05e2.16;
p 0.05) and that the OR of AAA was 3.75 (95% CI, 1.80e7.82;
p 0.001) for every unit increase (þ1 ln ngml1). The
association of fibrinogen with AAA even after adjustment
for other risk factors in these two studies supports the
independent link between fibrinogen and AAA.
It is unlikely that fibrinogen and D-dimer assessments
will replace ultrasonography as first-line diagnostic
modality to rule in or rule out the presence of AAA. It is
postulated, however, that biomarkers measured at
diagnosis or during follow-up might provide important
prognostic information about subsequent aortic behaviour,
allowing more patient-specific management compared with
relying on aortic diameter alone.1 Al-Barjas et al.6
demonstrated that fibrinogen level was positively corre-
lated with the size of AAA (rZ 0.323; p< 0.01). Yamazumi
et al.12 showed that the largest diameter of AAA correlated
with the levels of D-dimer (rZ 0.644, pZ 0.0001). Eng-
stro¨m et al.23 measured plasma fibrinogen in 6075 healthy
men (mean age: 46.8 3.7 years), and 63 men had a fatal
or surgically/endovascularly repaired AAA after a mean
time of 19 years. Fibrinogen was significantly associated
with future AAA after adjustments for age, screening year
and potential confounders (OR, 2.1; p< 0.01; when
comparing the risk in the top quartile vs. quartile 1ec3).
These findings, however, are inconclusive, and further
studies are needed to confirm whether plasma fibrinogen
and D-dimer concentrations have a role in predicting
subsequent progression or rupture of AAA.
Conflict of Interest
No conflicts of interest, no study sponsors.
Acknowledgements
No conflicts of interest declared.
References
1 Golledge J, Tsao PS, Dalman RL, Norman PE. Circulating
markers of abdominal aortic aneurysm presence and progres-
sion. Circulation 2008;118:2382e92.
2 Higgins JP, Green S, editors. Cochrane handbook for systematic
reviews of interventions Version 5.0.1 [updated September
2008]. The Cochrane Collaboration. Available from: www.
cochrane-handbook.org; 2008.
3 Begg CB, Mazumdar M. Operating characteristics of a rank
correlation test for publication bias. Biometrics 1994;50:
1088e101.
4 Review Manager (RevMan) [Computer program]. Version 5.0.
Copenhagen: The Nordic Cochrane Centre, The Cochrane
Collaboration; 2008.
5 Alberto P, Maddalena G, Giuseppe G, Ilaria Q, Franci B,
Campagna MS, et al. Prevalence of risk factors, coronary and
systemic atherosclerosis in abdominal aortic aneurysm:
comparison with high cardiovascular risk population. Vasc
Health Risk Manag 2008;4:877e83.
Plasma Fibrinogen/D-dimer and AAA Presence 2776 Al-BarjasHS, Arie¨ns R,Grant P, Scott JA. Raisedplasmafibrinogen
concentration in patients with abdominal aortic aneurysm.
Angiology 2006;57:607e14.
7 Fowkes FG, Anandan CL, Lee AJ, Smith FB, Tzoulaki I, Rumley A,
et al. Reduced lung function in patients with abdominal aortic
aneurysm is associated with activation of inflammation and
hemostasis, not smoking or cardiovascular disease. J Vasc Surg
2006;43:474e80.
8 Spring S, van der Loo B, Krieger E, Amann-Vesti BR, Rousson V,
Koppensteiner R. Decreased wall shear stress in the common
carotid artery of patients with peripheral arterial disease or
abdominalaorticaneurysm: relationtobloodrheology,vascular risk
factors, and intima-media thickness. J Vasc Surg 2006;43:56e63.
9 Singh K, Bønaa KH, Jacobsen BK, Bjørk L, Solberg S. Prevalence
of and risk factors for abdominal aortic aneurysms in a pop-
ulation-based study: The Tromsø Study. Am J Epidemiol 2001;
154:236e44.
10 Holmberg A, Bergqvist D, Westman B, Siegbahn A. Cytokine and
fibrinogen response in patients undergoing open abdominal
aortic aneurysm surgery. Eur J Vasc Endovasc Surg 1999;17:
294e300.
11 Blann AD, Devine C, Amiral J, McCollum CN. Soluble adhesion
molecules, endothelial markers and atherosclerosis risk factors
in abdominal aortic aneurysm: a comparison with claudicants
and healthy controls. Blood Coagul Fibrinolysis 1998;9:479e84.
12 Yamazumi K, Ojiro M, Okumura H, Aikou T. An activated state of
blood coagulation and fibrinolysis in patients with abdominal
aortic aneurysm. Am J Surg 1998;175:297e301.
13 Lee AJ, Fowkes FG, Lowe GD, Rumley A. Haemostatic factors,
atherosclerosis and risk of abdominal aortic aneurysm. Blood
Coagul Fibrinolysis 1996;7:695e701.
14 Franks PJ, Edwards RJ, Greenhalgh RM, Powell JT. Risk factors
for abdominal aortic aneurysms in smokers. Eur J Vasc Endovasc
Surg 1996;11:487e92.15 Milne AA, Adam DJ, Murphy WG, Ruckley CV. Effects of
asymptomatic abdominal aortic aneurysm on the soluble coag-
ulation system, platelet count and platelet activation. Eur J
Vasc Endovasc Surg 1999;17:434e7.
16 Fligelstone LJ, Cachia PG, Ralis H, Whattling P, Morgan RH,
Shandall AA, et al. Lupus anticoagulant in patients with
peripheral vascular disease: a prospective study. Eur J Vasc
Endovasc Surg 1995;9:277e83.
17 Skagius E, Siegbahn A, Bergqvist D, Henriksson AE. Fibrinolysis
in patients with an abdominal aortic aneurysm with special
emphasis on rupture and shock. J Thromb Haemost 2008;6:
147e50.
18 Serino F, Abeni D, Galvagni E, Sardella SG, Scuro A, Ferrari M,
et al. Noninvasive diagnosis of incomplete endovascular aneu-
rysm repair: D-dimer assay to detect type I endoleaks and
nonshrinking aneurysms. J Endovasc Ther 2002;9:90e7.
19 Aramoto H, Shigematsu H, Muto T. Perioperative changes in
coagulative and fibrinolytic function during surgical treatment
of abdominal aortic aneurysm and arteriosclerosis obliterans.
Int J Cardiol 1994;47(1 Suppl):S55e63.
20 Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM,
Humphries SE, et al. Interleukin-6 (IL-6) and the prognosis of
abdominal aortic aneurysms. Circulation 2001;103:2260e5.
21 Fatah K, Silveira A, Tornvall P, Karpe F, Blomba¨ck M, Hamsten A.
Proneness to formation of tight and rigid fibrin gel structures in
men with myocardial infarction at a young age. Thromb Hae-
most 1996;76:535e40.
22 Mills JD, Arie¨ns RA, Mansfield MW, Grant PJ. Altered fibrin clot
structure in the healthy relatives of patients with premature
coronary artery disease. Circulation 2002;106:1938e42.
23 Engstro¨m G, Bo¨rner G, Lindblad B, Janzon L, Lindga¨rde F.
Incidence of fatal or repaired abdominal aortic aneurysm in
relation to inflammation-sensitive plasma proteins. Arterioscler
Thromb Vasc Biol 2004;24:337e41.
